Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 3.42 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; sodium hydroxide - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; benzalkonium chloride; water for injections - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - tropicamide, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; benzalkonium chloride; purified water; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at 14 july 2003 : used to produce mydriasis and cycloplegia for diagnostic purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - tropicamide, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; disodium edetate; purified water; benzalkonium chloride; hydrochloric acid - indications as at 14 july 2003 : used to produce mydriasis and cycloplegia for diagnostic purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 40 mg/ml - eye drops, solution - excipient ingredients: boric acid; sodium citrate dihydrate; purified water; benzalkonium chloride; hypromellose - in the treatment of glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 20 mg/ml - eye drops, solution - excipient ingredients: sodium citrate dihydrate; purified water; boric acid; hypromellose; benzalkonium chloride - in the treatment of glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: sodium citrate dihydrate; boric acid; hypromellose; purified water; sodium chloride; benzalkonium chloride - in the treatement of glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - cyclopentolate hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: potassium chloride; purified water; hydrochloric acid; benzalkonium chloride; boric acid; disodium edetate; sodium carbonate monohydrate - indications as at 27 june 1996: for mydriasis nad cycloplegia in diagnostic procedures. for some pre- and post-operative states when mydriasis is required and when a shorter acting mydriatic and cycloplegic is needed in the therapy of iridocyclitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - phenylephrine hydrochloride, quantity: 1.2 mg/ml; prednisolone acetate, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: benzalkonium chloride; sodium metabisulfite; sodium citrate dihydrate; sodium chloride; boric acid; hypromellose; disodium edetate; phenazone; polysorbate 80; purified water; hydrochloric acid; sodium hydroxide - severe inflammation (non-infectious) of the eye, such as acute iritis, iridocyclitis, scleritis, episcleritis, uveitis, resistant ocular allergy and inflammation following surgery (where no infectious aetiology is suspected), particularly where unusually rapid control of the inflammation is required.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - polymyxin b sulfate; prednisolone acetate; miconazole nitrate - misc. aural, ophthalmic, oro/naso pharyngeal - polymyxin b sulfate antibiotic active 0.696 mg/ml; prednisolone acetate steroid-glucocorticoid active 5.0 mg/ml; miconazole nitrate triazole active 23.0 mg/ml - ear,nose,throat preps. - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - ear mange mite | infections of the skin | otitis externa | abscesses | acute canine otitis | anal sacculitis | associated with yeast &/or bac | chronic canine otitis | ear mites | fungal | gingivitis | gram negative bacteria | gram positive bacteria | malassezia pachydermatis | otitis (canine) | post-parturient infections | pyoderma | septicaemia | yeast